Anna Remková

448 total citations
31 papers, 353 citations indexed

About

Anna Remková is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Organic Chemistry. According to data from OpenAlex, Anna Remková has authored 31 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Organic Chemistry. Recurrent topics in Anna Remková's work include Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Blood Pressure and Hypertension Studies (4 papers) and Free Radicals and Antioxidants (4 papers). Anna Remková is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Blood Pressure and Hypertension Studies (4 papers) and Free Radicals and Antioxidants (4 papers). Anna Remková collaborates with scholars based in Slovakia, Netherlands and India. Anna Remková's co-authors include Milan Remko, Milan Remko, Helena Kratochvílová, Ria Broer, Iveta Šimková, Joanna Bojarska, Waldemar Maniukiewicz, Jiří Veselý, Piet Th. van Duijnen and Emὄke Šteňová and has published in prestigious journals such as International Journal of Molecular Sciences, Chemical Physics Letters and Molecules.

In The Last Decade

Anna Remková

30 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Remková Slovakia 12 123 71 56 48 45 31 353
Joseph L. Lambing United States 9 258 2.1× 16 0.2× 90 1.6× 25 0.5× 110 2.4× 15 442
Tsukasa Ishihara Japan 15 242 2.0× 29 0.4× 109 1.9× 36 0.8× 164 3.6× 45 600
Jessica Rehmel United States 9 203 1.7× 35 0.5× 56 1.0× 46 1.0× 38 0.8× 15 371
Wolfgang G. Eisert Germany 10 218 1.8× 60 0.8× 23 0.4× 115 2.4× 55 1.2× 20 453
Satoru Nagashima Japan 15 94 0.8× 40 0.6× 26 0.5× 18 0.4× 135 3.0× 41 565
H. Narjes Germany 11 69 0.6× 84 1.2× 75 1.3× 13 0.3× 111 2.5× 17 461
Joe Murphy United States 6 89 0.7× 25 0.4× 16 0.3× 62 1.3× 99 2.2× 8 395
Janice Rischke Canada 11 149 1.2× 65 0.9× 18 0.3× 104 2.2× 48 1.1× 16 396
Anna Abrahamsson Sweden 15 157 1.3× 54 0.8× 17 0.3× 118 2.5× 132 2.9× 19 816
Silvia Villa Italy 12 174 1.4× 90 1.3× 20 0.4× 50 1.0× 47 1.0× 26 546

Countries citing papers authored by Anna Remková

Since Specialization
Citations

This map shows the geographic impact of Anna Remková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Remková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Remková more than expected).

Fields of papers citing papers by Anna Remková

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Remková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Remková. The network helps show where Anna Remková may publish in the future.

Co-authorship network of co-authors of Anna Remková

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Remková. A scholar is included among the top collaborators of Anna Remková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Remková. Anna Remková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Remková, Anna, et al.. (2023). Dental interventions in oral antithrombotic therapy. Vnitřní lékařství. 69(1). 31–36. 1 indexed citations
2.
3.
Remková, Anna & Milan Remko. (2019). May warfarin prevent cancer?. Vnitřní lékařství. 65(11). 679–684. 1 indexed citations
4.
Remko, Milan, Ria Broer, Anna Remková, & Piet Th. van Duijnen. (2017). Structure and stability of complexes of agmatine with some functional receptor residues of proteins. Chemical Physics Letters. 673. 44–49. 3 indexed citations
5.
Remková, Anna, et al.. (2016). Risk factors detection in chronic thromboembolic pulmonary hypertension, a tool for risk quantification?. Bratislavské lekárske listy/Bratislava medical journal. 117(10). 577–582. 9 indexed citations
6.
Remková, Anna, et al.. (2016). Platelet abnormalities in adults with severe pulmonary arterial hypertension related to congenital heart defects (Eisenmenger syndrome). Blood Coagulation & Fibrinolysis. 27(8). 925–929. 12 indexed citations
8.
Remko, Milan, Ria Broer, Anna Remková, & Piet Th. van Duijnen. (2014). How strong are Ca2+–heparin and Zn2+–heparin interactions?. Chemical Physics Letters. 621. 12–17. 5 indexed citations
9.
Remková, Anna, et al.. (2012). [Is antiplatelet therapy always effective?].. PubMed. 58(12). 904–14. 2 indexed citations
10.
Remková, Anna, et al.. (2010). A severe renal bleeding as a complication of coumarin therapy in Behçet's disease. Blood Coagulation & Fibrinolysis. 21(5). 487–490. 1 indexed citations
11.
Remková, Anna & Milan Remko. (2010). [Markers of endothelial function in the early stages of essential hypertension and the effect of antihypertensive therapy].. PubMed. 56(12). 1210–6. 2 indexed citations
12.
Remková, Anna & Milan Remko. (2010). The Role of Renin-Angiotensin System in Prothrombotic State in Essential Hypertension. Physiological Research. 59(1). 13–23. 53 indexed citations
13.
Remková, Anna & Milan Remko. (2009). Homocysteine and endothelial markers are increased in patients with chronic liver diseases. European Journal of Internal Medicine. 20(5). 482–486. 20 indexed citations
14.
Remková, Anna, et al.. (2009). General changes in hemostasis in gastric cancer.. PubMed. 110(4). 215–21. 8 indexed citations
16.
Remková, Anna, et al.. (2007). Acute vasculitis as a first manifestation of hairy cell leukemia. European Journal of Internal Medicine. 18(3). 238–240. 5 indexed citations
17.
Remková, Anna, et al.. (2003). B cell chronic lymphocytic leukemia with meningeal infiltration by T lymphocytes. European Journal of Internal Medicine. 14(1). 49–52. 12 indexed citations
18.
Remková, Anna & Helena Kratochvílová. (2002). Effect of the new centrally acting antihypertensive agent rilmenidine on endothelial and platelet function in essential hypertension. Journal of Human Hypertension. 16(8). 549–555. 10 indexed citations
19.
Remková, Anna & Helena Kratochvílová. (2000). Effect of the angiotensin-converting enzyme inhibitor perindopril on haemostasis in essential hypertension. Blood Coagulation & Fibrinolysis. 11(7). 641–644. 13 indexed citations
20.
Remková, Anna, et al.. (2000). Thrombomodulin as a marker of endothelium damage in some clinical conditions. European Journal of Internal Medicine. 11(2). 79–84. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026